|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
CONCURRENT USE WITH ASTEMIZOLE, REPORTED TO SIGNIFICANTLY ALTER THE METABOLISM OF ASTEMIZOLE; RARE CASES OF CARDIOVASCULAR ADVERSE EVENTS,LIKE PROLONGED QT INTERVAL, CARDIAC ARREST,TORSADE DE POINTES, AND VENTRICULAR ARRHYTHMIAS HAVE BEEN REPORTED
|
INCREASED SEDATIVE EFFECT
|
GATIFLOXACIN MAY HAVE THE POTENTIAL TO PROLONG THE QT INTERVAL ; CO-ADMINISTRATION WITH DRUGS KNOWN TO PROLONG QT INTERVAL SHOULD BE AVOIDED
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
HALOPERIDOL BLOCKS DOPAMINE RECEPTORS, THUS INHIBITING THE CENTRAL STIMULAT EFFECTS OF AMPHETAMINE
|
INCREASED RISK OF EXTRAPYRAMIDAL SIDE EFFECTS
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
ANTIPSYCHOTICS MAY ANTAGONISE THE ANTIEPILEPTIC ACTIVITY OF ANTIEPILEPTICS INCLUDING PHENOBARBITONE BY LOWERING THE CONVULSIVE THRESHOLD
|
DOPAMINE ANTAGONISTS MAY DIMINISH THE EFFECTIVENESS OF DOPAMINE AGONISTS LIKE PRAMIPEXOLE & OTHERS
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
LEVODOPA EFFECT IS REDUCED BY THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
TRICYCLIC ANTIDEPRESSANTS METABOLISM IS REDUCED BY THE DRUG LEADING TO INCREASED SERUM LEVELS OF TRICYCLIC ANTIDEPRESSANTS AND POSSIBLE TOXICITY
|
ALCOHOL MAY CAUSE DYSTONIA & AKATHISIA IF GIVEN CONCURRENTLY WITH THE DRUG & MAY HAVE INCREASED SEDATIVE EFFECT
|
ALCOHOL MAY CAUSE DYSTONIA & AKATHISIA IF GIVEN CONCURRENTLY WITH THE DRUG & MAY HAVE INCREASED SEDATIVE EFFECT
|
ALCOHOL MAY CAUSE DYSTONIA & AKATHISIA IF GIVEN CONCURRENTLY WITH THE DRUG & MAY HAVE INCREASED SEDATIVE EFFECT
|
ALCOHOL MAY CAUSE DYSTONIA & AKATHISIA IF GIVEN CONCURRENTLY WITH THE DRUG & MAY HAVE INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION WITH RANOLAZINE MAY INCREASE ITS PLASMA LEVELS
|
SERUM LEVELS OF HALOPERIDOL MAY INCREASE ON CO-ADMINISTRATION
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
NSAIDS MAY CAUSE SEVERE DROWSINESS & CONFUSION WHEN CONCURRENTLY ADMINISTERED
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|